Botannis Labs, Inc. is a third-party testing and compliance organization, founded in 2018, with the mission of serving FDA-regulated and state-licensed nutraceutical and pharmaceutical companies. Headquartered in the United States, Botannis aims to provide comprehensive services to ensure the success of its clients. Despite the absence of publicly disclosed investment information at present, the company's commitment to quality assurance and regulatory compliance positions it as a promising player in the nutraceutical and pharmaceutical industries. With the increasing focus on product safety and compliance, Botannis Labs has the potential to attract interest from venture capital firms seeking opportunities in the healthcare and regulatory sectors.
There is no investment information
No recent news or press coverage available for Botannis Labs, Inc..